CGTLimited DatastaleAMERICAN ORGAN TRANSPLANT AND C…Phase 2
Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney (Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney)
End-Stage Renal Disease; End Stage Renal Disease on Dialysis · End-Stage Renal Disease
#End-StageRenalDisease#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting